Basophil count is a sensitive marker for clinical progression in a chronic spontaneous urticaria patient treated with omalizumab

Publication date: Available online 18 February 2019

Source: Allergology International

Author(s): Izumi Kishimoto, Naotomo Kambe, Nhung Thi My Ly, Chuyen Thi Hong Nguyen, Hiroyuki Okamoto

http://bit.ly/2SKV1HT